However, few studies assessing postural control in patients with

However, few studies assessing postural control in patients with PD included homogeneous population in late stage of the disease. Thus, this study aimed to analyse postural control and strategies in a homogeneous population of patients with idiopathic

advanced (late-stage) PD, and to determine the contribution of peripheral inputs in simple and more complex postural tasks, such as sensory conflicting and dynamic tasks. Twenty-four subjects with advanced PD (duration: median (M)=11.0 years, interquartile range (IQR)=4.3 years; Unified Parkinson’s Disease Rating Scale (UPDRS): M “”on-dopa”"=13.5, IQR=7.8; UPDRS: M “”off-dopa”"=48.5, IQR=16.8; Hoehn and Yahr stage IV in all patients) and 48 age-matched healthy controls underwent static (SPT) and dynamic posturographic (DPT) tests and a sensory organization test (SOT). In SPT, patients with PD showed reduced postural control precision AZD0156 concentration with increased oscillations in both anterior posterior and medial lateral planes. In SOT, patients with PD displayed reduced postural performances especially BMS-777607 supplier in situations in which visual and vestibular cues became predominant

to organize balance control, as was the ability to manage balance in situations for which visual or proprioceptive inputs are disrupted. In OPT, postural restabilization strategies were often inefficient to maintain equilibrium resulting in falls. Postural strategies were often precarious, postural regulation involving more hip joint than ankle joint in patients with advanced PD than in controls. Difficulties in managing complex postural situations, such as sensory conflicting and dynamic situations might reflect an inadequate sensory organization suggesting impairment in central information processing. (C) 2011 Published by Elsevier Ltd on behalf of IBRO.”
“Manual acupuncture (MA) has presented analgesic activity against neuropathic pain in patients and animal models, yet

a series of questions remain: Is BIX 1294 solubility dmso MA effectiveness dependent of acupoint selection or combination? Is it equally efficient when treatment starts on the initial (acute) or subchronic phase of spinal nerve ligation (SNL)-induced neuropathy? Is MA effect related to the release of endogenous opioids? Does MA produce similar effects to gabapentin? To answer these questions rats submitted to the L5/L6 SNL injury were treated with unilateral MA (ST36 (Zusanli), SP6 (Sanyingjiao) or ST36+SP6 acupoint stimulation); or with gabapentin (30 mg/kg i.p., used as positive control). Both acupoints have been demonstrated to present analgesic activity and are used in clinical practice and basic science research. In addition, we investigated the influence of naloxone (1 mg/kg i.p., a nonselective opioid receptor antagonist) on MA treatment and also the effect of unilateral ST36+SP6 MA treatment beginning acutely (5 days) or sub-chronically (14 days) after SNL.

Comments are closed.